MEXICO CITY: The Mexico Federal Commission for the Protection Against Sanitary Risk (Cofepris) on Wednesday has granted authorization for the emergency use of India’s first domestically-produced COVID-19 vaccine, Covaxin.
“The decision by Cofepris to authorize the emergency use of the Covaxin vaccine produced in India was made very timely. Mexico’s COVID-19 vaccination opportunities are expanding,” Mexican Foreign Minister Marcelo Ebrard stated in a tweet.
Muy oportuna decisión de COFEPRIS de autorizar el uso de emergencia de la vacuna COVAXINE fabricada en la India . Se amplían las opciones para la vacunacion contra COVID-19 en México!!!
— Marcelo Ebrard C. (@m_ebrard) April 6, 2021
Since the start of the vaccination marketing campaign, the Mexican authorities have distributed over 9.6 million doses of vaccines, primarily among the many aged and medical doctors. The large marketing campaign started within the second half of February, reported Sputnik.
Currently, there are 5 completely different vaccines which are being utilized in Mexico, both bought from overseas or produced locally–Pfizer/BioNTech, Oxford/AstraZeneca, Sinovac, Cansino, and Sputnik V. According to Johns Hopkins University, Mexico has a complete of two,256,509 COVID-19 circumstances. As many as 204,985 individuals have died thus far within the nation.